Syphilis Immunoassay Diagnostics Market Size, Share, Trends, Growth, Forecasts, 2032

Syphilis Immunoassay Diagnostics Market

Syphilis Immunoassay Diagnostics Market By End-user (diagnostic labs, blood banks, hospitals, and others), By product (kits, reagents, analyzers, and others), By type (secondary syphilis and primary syphilis), By technology (enzyme-linked immunosorbent assay and chemiluminescence immunoassay) And By Region: - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts, 2024-2032

Category: Medical Device Report Format : PDF Report Code: ZMR-6512 Status : Upcoming
Market Size in 2023 Market Forecast in 2032 Growth Rate (in %) Base Year
USD 545.81 Million USD 712.61 Million CAGR at 2.98% 2023

Syphilis Immunoassay Diagnostics Market

Description

According to the report published by Zion Market Research, the global Syphilis Immunoassay Diagnostics Market size was valued at USD 545.81 Million in 2023 and is predicted to reach USD 712.61 Million by the end of 2032. The market is expected to grow with a CAGR of 2.98% during the forecast period. The report analyzes the global Syphilis Immunoassay Diagnostics Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Syphilis Immunoassay Diagnostics Market industry.

Global Syphilis Immunoassay Diagnostics Market Size, 2018-2032Request Free Sample

Global Syphilis Immunoassay Diagnostics Market: Overview

Syphilis is a chronic bacterial disease that is spread by sexual activity. It can be cured with antibiotics, especially in the early stage. It is a sexually transmitted infection spread by bacteria named, Treponema pallidum that possesses long-term complications if not diagnosed and treated early. The disease is diagnosed with the help of serology testing and clinical findings. The serological diagnosis of syphilis includes the identification and detection of different kinds of antibodies namely, non-treponemal and treponemal antibodies. The syphilis prototype is reallocated around several centers to diagnose the treponemal antibody test if there is a positive test report for treponemal antibody. There are different types of methods utilized for its diagnoses, including enzyme immunoassay (EIA) test, venereal disease research laboratory (VDRL) test, RPR test, and others. The diagnosis of syphilis depends on the level of clinical suspicion and routine screening for the patients at higher risk.

Global Syphilis Immunoassay Diagnostics Market: Growth Factors

Syphilis is a global health concern due to its constantly growing incidences, particularly among bisexual and gay people. Thereby, it is likely to fuel the growth of the global syphilis immunoassay diagnostics market during the forecast period. However, the growing cases of anonymous sex, sex under the influence of dangerous drugs, sex with multiple partners, and also the growing number of unprotected sex both oral & anal will complement the growth of the market. Also, there is significant prominence of syphilis in pregnant women due to sexual intercourse with infected partners which leads to congenital abnormalities like stillbirth and other complications in pregnancy.

The ongoing technological advancements in analyzer technology are likely to create several lucrative growth opportunities in the field of syphilis immunoassay diagnostics. However, the surge in the demand for analyzers in blood banks and hospitals is likely to further boost the growth of the global syphilis immunoassay diagnostics market during the forecast period. The utilization of several advanced computing techniques like artificial intelligence and machine learning in laboratory diagnosis will facilitate a high level of accuracy and high-quality testing facility.

The manufacturers are enhancing their testing abilities with innovative software to improve the testing facility. There is a significant surge in the trend of on-the-spot testing, which in turn will drive the growth of the market.

Syphilis Immunoassay Diagnostics MarketRequest Free Sample

Global Syphilis Immunoassay Diagnostics Market: Segmentation

The global syphilis immunoassay diagnostics market can be segmented into end-user, product, type, technology, and region.

By end-user, the market can be segmented into diagnostic labs, blood banks, hospitals, and others. The diagnostic lab segment dominates the global syphilis immunoassay diagnostics market.

By product, the market can be segmented into kits, reagents, analyzers, and others.

By type, the market can be segmented into secondary syphilis and primary syphilis.

By technology, the market can be segmented into enzyme-linked immunosorbent assay and chemiluminescence immunoassay. The chemiluminescence immunoassay segment accounts for the largest share in the global syphilis immunoassay diagnostics market due to the lower turnaround and higher efficiency.

Syphilis Immunoassay Diagnostics Market : Report Scope

Report Attributes Report Details
Report Name Syphilis Immunoassay Diagnostics Market Research Report
Market Size in 2023 USD 545.81 Million
Market Forecast in 2032 USD 712.61 Million
Growth Rate CAGR of 2.98%
Number of Pages 196
Key Companies Covered Hoffmann-La Roche Ltd, Fujirebio, bioMérieux SA, DiaSorin S.p.A., Shenzhen New Industries Biomedical Engineering Co., Ltd., Ortho Clinical Diagnostics, Abbott Laboratories, F. Dickinson and Company, Becton, Danaher, Siemens Healthineers AG, and Bio-Rad Laboratories, Inc.
Segments Covered By End-user, By product, By type, By technology and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Syphilis Immunoassay Diagnostics Market: Regional analysis

North America accounts for the largest share in the global syphilis immunoassay diagnostics market due to the adoption of advanced technology for screening tests along with growing initiatives from the government to lower the growing incidences of syphilis infections in the region. Furthermore, the growing awareness among people regarding the early diagnosis and treatment of syphilis will further escalate the growth of the regional market.

Asia Pacific is expected to witness a significant growth rate in the forthcoming years due to the ongoing technological advancements in diagnostic technology in the region.

Global Syphilis Immunoassay Diagnostics Market: Competitive Players

Some of the significant players in the global syphilis immunoassay diagnostics market are :

  • Hoffmann-La Roche Ltd
  • Fujirebio
  • bioMérieux SA
  • DiaSorin S.p.A.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Ortho Clinical Diagnostics
  • Abbott Laboratories
  • F. Dickinson and Company
  • Becton, Danaher
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.

The Global Syphilis Immunoassay Diagnostics Market is segmented as follows:

By End-user 

  • diagnostic labs 
  • blood banks 
  • hospitals 
  • and others 

By product 

  • kits 
  • reagents
  • analyzers
  • and others

By type 

  • secondary syphilis
  • primary syphilis

 By technology 

  • enzyme-linked immunosorbent assay 
  • chemiluminescence immunoassay 

Global Syphilis Immunoassay Diagnostics Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

  • zion payment modes

FrequentlyAsked Questions

Syphilis is a global health concern due to its constantly growing incidences, particularly among bisexual and gay people. Thereby, it is likely to fuel the growth of the global syphilis immunoassay diagnostics market during the forecast period. However, the growing cases of anonymous sex, sex under the influence of dangerous drugs, sex with multiple partners, and also the growing number of unprotected sex both oral and anal will complement the growth of the market.

Some of the significant players in the global syphilis immunoassay diagnostics market are Hoffmann-La Roche Ltd, Fujirebio, bioMérieux SA, DiaSorin S.p.A., Shenzhen New Industries Biomedical Engineering Co., Ltd., Ortho Clinical Diagnostics, Abbott Laboratories, F. Dickinson and Company, Becton, Danaher, Siemens Healthineers AG, and Bio-Rad Laboratories, Inc.

 

North America accounts for the largest share in the global syphilis immunoassay diagnostics market due to the adoption of advanced technology for screening tests along with growing initiatives from the government to lower the growing incidences of syphilis infections in the region.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed